Publications by authors named "Mark D Danese"

Claim this Profile
I
Imaging Utilization and Treatment Patterns of Brain Metastases in Patients With Non-Small Cell Lung Cancer: A SEER-Medicare and SEER Database Analysis.
Mark D Danese, Jason Shafrin, Melissa Laurie, Beata Korytowsky, Shane Jordan

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma.
Mark D Danese, John S Groundland

J Natl Cancer Inst· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Liu, Xiao, Liu, et al.
Mark D Danese, John S Groundland

J Natl Cancer Inst· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an algorithm to identify small cell lung cancer patients in claims databases.
Mark D Danese, Akhila Balasubramanian, D Gwyn Bebb, Xerxes Pundole

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare Data.
Mark D Danese, Kabir Mody, Ramya Thota, Stacie C Lindsey, Melinda Bachini

Gastro Hep Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.
Mark D Danese, Melinda Daumont, Esmond Nwokeji, Michelle Gleeson, John R Penrod

Cancer Rep (Hoboken)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer.
Mark D Danese, Jennifer Schenfeld, Jaime Shaw, Prasad Gawade, Akhila Balasubramanian

Adv Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rate, cost and outcomes of parathyroidectomy in the united states dialysis population from 2016-2018.
Mark D Danese, Kathleen M Fox, Jennifer L Duryea, Pooja Desai, Robert J Rubin

BMC Nephrol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
Mark D Danese, Deborah Lubeck, Vasily Belozeroff, Tzu-Chieh Lin, Pooja Desai

Am J Nephrol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom.
Mark D Danese, Peter Pemberton-Ross, David Catterick, Guillermo Villa

Eur J Prev Cardiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial.
Geoffrey A Block, Glenn M Chertow, Kerry Cooper, Shan Xing, Bruno Fouqueray, Mark D Danese

Hemodial Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data.
Mark D Danese, Aaron Katz, Karynsa Cetin, Victoria Chia, Michelle L Gleeson

Leuk Lymphoma· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Generalized Data Model for clinical research.
Mark D Danese, Marc Halperin, Jennifer Duryea, Ryan Duryea

BMC Med Inform Decis Mak· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Kamlesh Khunti, Mark D Danese, Lucie Kutikova, David Catterick, Francisco Sorio-Vilela

JAMA Netw Open· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study.
Mark D Danese, Eduard Sidelnikov, Lucie Kutikova

Curr Med Res Opin· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom.
Mark D Danese, Michelle Gleeson, Robert I Griffiths, David Catterick, Lucie Kutikova

J Med Econ· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
Mark D Danese, Robert I Griffiths, Michelle L Gleeson, Tapashi Dalvi, Jingyi Li

Leuk Lymphoma· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study.
Mark D Danese, Michelle Gleeson, Lucie Kutikova, Robert I Griffiths, Kamlesh Khunti

BMJ Open· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.
Geoffrey A Block, Akeem A Yusuf, Mark D Danese, Heidi S Wirtz, Yan Hu

BMC Nephrol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK.
Mark D Danese, Michelle Gleeson, Lucie Kutikova, Robert I Griffiths, Ali Azough

BMJ Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States.
Kimberly A Lowe, Mark D Danese, Michelle L Gleeson, Wendy J Langeberg, Juan Ke

J Gastrointest Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data.
Mark D Danese, Carolina M Reyes, Michelle L Gleeson, Marc Halperin, Sandra L Skettino

Med Care· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
Deborah P Lubeck, Mark D Danese, Jennifer Duryea, Marc Halperin, Darren Tayama

Int J Stroke· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States.
Mark D Danese, Anthony Masaquel, Eduardo Santos, Melissa Brammer, Abraham Lee

Value Health· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.
Mark D Danese, Marc Halperin, Kimberly A Lowe, Brian D Bradbury, Thy P Do

Nephrol Dial Transplant· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis